Evidence map›Paper›PMID 34937990›Full record

ArticleEthics & international affairs2021

On the Ethics of Vaccine Nationalism: The Case for the Fair Priority for Residents Framework.

Ezekiel J Emanuel, Allen Buchanan, Shuk Ying Chan, Cécile Fabre, Daniel Halliday, R J Leland, Florencia Luna, Matthew S McCoy, Ole F Norheim, G Owen Schaefer and 2 more

Open access · greenAbstract read
In one paragraph

Article in Ethics & international affairs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Pandemic justice for and from Latin America.Ethic@ : an international journal for moral philosophy = Revista internacional de filosofia da moral · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 7 countries.

Ezekiel J EmanuelPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Allen BuchananUniversity of Arizona, Tucson, Arizona, United States.
Shuk Ying ChanNuffield College, University of Oxford, Oxford, England.
Cécile FabreAll Souls College, Oxford, United Kingdom; University of Oxford, Oxford, United Kingdom.
Daniel HallidayUniversity of Melbourne, Australia.
R J LelandUniversity of Manitoba, Winnipeg, Manitoba, Canada.
Florencia LunaFLACSO-CONICET, Buenos Aires, Argentina.
Matthew S McCoyUniversity of Pennsylvania, Philadelphia, Pennsylvania, United States.
Ole F NorheimUniversity of Bergen, Bergen, Norway.
G Owen SchaeferYong Loo Lin School of Medicine, National University of Singapore, Singapore.
Kok-Chor TanUniversity of Pennsylvania, Philadelphia, Pennsylvania, United States.
Christopher Heath WellmanWashington University in St. Louis, Missouri, United States.
University of Pennsylvania · USFacultad Latinoamericana de Ciencias Sociales · ARNational University of Singapore · SGUniversity of Arizona · USUniversity of Bergen · NOUniversity of Manitoba · CAUniversity of Melbourne · AUUniversity of Oxford · GBWashington University in St. Louis · US

Funding

Training Program in Research Ethics in the AmericasR25TW001605 · FIC · YESHIVA UNIVERSITY · PI LUNA, FLORENCIA · 2000 to 2025
$6.7M
FIC NIH HHS R25 TW001605
6 · The paper itself

Abstract

COVID-19 vaccines are likely to be scarce for years to come. Many countries, from India to the U.K., have demonstrated vaccine nationalism. What are the ethical limits to this vaccine nationalism? Neither extreme nationalism nor extreme cosmopolitanism is ethically justifiable. Instead, we propose the fair priority for residents (FPR) framework, in which governments can retain COVID-19 vaccine doses for their residents only to the extent that they are needed to maintain a noncrisis level of mortality while they are implementing reasonable public health interventions. Practically, a noncrisis level of mortality is that experienced during a bad influenza season, which society considers an acceptable background risk. Governments take action to limit mortality from influenza, but there is no emergency that includes severe lockdowns. This "flu-risk standard" is a nonarbitrary and generally accepted heuristic. Mortality above the flu-risk standard justifies greater governmental interventions, including retaining vaccines for a country's own citizens over global need. The precise level of vaccination needed to meet the flu-risk standard will depend upon empirical factors related to the pandemic. This links the ethical principles to the scientific data emerging from the emergency. Thus, the FPR framework recognizes that governments should prioritize procuring vaccines for their country when doing so is necessary to reduce mortality to noncrisis flu-like levels. But after that, a government is obligated to do its part to share vaccines to reduce risks of mortality for people in other countries. We consider and reject objections to the FPR framework based on a country: (1) having developed a vaccine, (2) raising taxes to pay for vaccine research and purchase, (3) wanting to eliminate economic and social burdens, and (4) being ineffective in combating COVID-19 through public health interventions.

Indexed as

cosmopolitanismCOVID-19fair prioritymortalitynationalismvaccines

Identifiers

PMID34937990
PMCPMC8691804
OpenAlexW3209069654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.